Moreover, the loss of DYNLL1 dramatically delays the development and expansion of MYC-driven B-cell lymphoma in mice due to increased BIM-mediated apoptotic cell death, although BIM levels are not elevated [42]. This evidence concerns the gene MYC and B-cell non-Hodgkin lymphoma.